---
title: "Allarity Therapeutics CEO to Present at Precision Medicine Forum Europe 2026 in Stockholm | ALLR Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285727236.md"
description: "Allarity Therapeutics CEO to Present at Precision Medicine Forum Europe 2026 in Stockholm | ALLR Stock News"
datetime: "2026-05-08T04:45:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285727236.md)
  - [en](https://longbridge.com/en/news/285727236.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285727236.md)
---

# Allarity Therapeutics CEO to Present at Precision Medicine Forum Europe 2026 in Stockholm | ALLR Stock News

Allarity Therapeutics CEO to Present at Precision Medicine Forum Europe 2026 in Stockholm | ALLR Stock News

### Related Stocks

- [ALLR.US](https://longbridge.com/en/quote/ALLR.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)

## Related News & Research

- [Allarity Therapeutics secures CLIA certification for in-house DRP testing lab](https://longbridge.com/en/news/291945556.md)
- [Allarity Therapeutics wins key US patent for stenoparib DRP companion diagnostic through 2042](https://longbridge.com/en/news/291279513.md)
- [Allarity Therapeutics to present Phase 2 stenoparib ovarian cancer trial design at ESMO gynecological cancers congress](https://longbridge.com/en/news/290433741.md)
- [Allarity Therapeutics Q2 FY26 net loss widens to $3.41 million; comprehensive loss narrows to $3.67 million](https://longbridge.com/en/news/295931319.md)
- [06:00 ETNKF Honors Vertex with 2026 Kidney Biotech Innovation Award](https://longbridge.com/en/news/285351074.md)